Diabetes Mellitus Type 2 News

• SGLT-2 inhibitors as First-Line Therapy in Type 2 Diabetes? Real-world study finds heart failure hospitalization reduction compared to metformin but not MI, stroke, or overall mortality, and greater genital infection risk.
  Medscape Medical News, May 23, 2022
• Tirzepatide's Retail Price Set at About $12,666 Per Year The recently approved twincretin will carry a US retail price similar to one of its main competitors, semaglutide, but patient discounts will be available.
  Medscape Medical News, May 20, 2022
• Erectile Dysfunction in Diabetes May Be Underestimated Erectile dysfunction is common even among men within a year of their diabetes diagnosis. A researcher from the German Diabetes Center discusses what is known about this problem.
  Medscape Medical News, May 20, 2022
• Pancreatic Involvement in COVID-19: What Do We Know? Data indicate that the pancreas as a target of SARS-CoV-2 infection and suggest that pancreatic beta cell involvement could contribute to the metabolic dysregulation seen in patients with COVID-19.
  Medscape Medical News, May 19, 2022
• AACE 2022 Spinal Cord Stimulation Durable for Painful Diabetic Neuropathy Randomized controlled trial shows durable relief of refractory painful diabetic neuropathy symptoms with the spinal cord stimulation device out to 18 months.
  Medscape Medical News, May 17, 2022
• Alert Tirzepatide (Mounjaro) Gets FDA Approval for Type 2 Diabetes Endocrinologists voice enthusiasm for the first approved agent for patients with type 2 diabetes that is a dual incretin agonist, but they also express concern about cost and patient accessibility.
  FDA Approvals, May 13, 2022
• Low-Calorie Ketogenic Diet Improves Immune Function In patients with obesity, a very-low-calorie ketogenic diet induces significant weight loss and has positive immunomodulatory properties, according to accumulating evidence.
  Medscape Medical News, May 13, 2022
• Diabetes Doubles Risk of Death From COVID-19; East-West Divide? 'These findings are interesting because they reveal that worse outcomes due to COVID-19 in people with diabetes can be reduced in the right setting,' says an expert.
  Medscape Medical News, May 13, 2022
• Arkansas Sues Drugmakers, Pharmacy Benefit Managers Over Insulin Costs Arkansas's attorney general on Wednesday accused drugmakers and pharmacy benefit managers of colluding to drive up the price of insulin drugs, the latest in a series of lawsuits to take aim at skyrocketing insulin costs.
  Reuters Health Information, May 11, 2022
• Grit Your Teeth for a Lesser-Known Complication of Diabetes In addition to neuropathy, nephropathy, cardiovascular disease, and kidney disease, tooth loss is a lesser-known potential complication of type 2 diabetes. A large meta-analysis quantifies the risk.
  Medscape Medical News, May 11, 2022
• Screening for Diabetes at Normal BMIs Could Cut Racial Disparities Authors suggest diabetes screening for Asian and Black individuals aged 35 and over, even at BMIs that are not considered overweight, would be 'a good place to start' to reduce disparities.
  Medscape Medical News, May 09, 2022
• Periodontitis May Be Linked With Systemic Diseases Periodontitis may be associated with Alzheimer's disease and other chronic disorders, according to epidemiologic studies. The data suggest the importance of oral health for overall health.
  Medscape Medical News, May 09, 2022
• Use of Newer Type 2 Diabetes Drugs Gives Hope but Costs a Concern 'It's not just about lowering blood sugar. It's about reducing cardiovascular events, reducing the progression of kidney disease, and preventing death,' says one expert discussing benefits versus costs of treatments.
  Medscape Medical News, May 09, 2022
• US Elections May Thwart Democratic Effort to Cap Insulin Cost US lawmakers attempting to cut the cost of insulin for more than a million Americans to $35 per month are unlikely to succeed as November elections draw near and complicate bipartisan support, health policy, and political experts say.
  Reuters Health Information, May 06, 2022
• Higher Magnesium Links With Better Bariatric Surgery Outcomes A review of 403 patients with type 2 diabetes who underwent bariatric surgery showed that higher magnesium levels were associated with better post-surgical glycemic control and diabetes remission.
  First Look, May 09, 2022
• ECO 2022 Vegan Diet Helps Shed Pounds but Doesn't Dint Diabetes A systematic review of vegan diets compared with usual diet and other weight loss regimens in overweight and diabetes shows greater weight loss on the vegan diet, on average, but minimal effect on A1c.
  Medscape Medical News, May 06, 2022
• Type 2 Diabetes, Hypoglycemia Worsen Heart Failure Hospitalizations Among 783 Koreans hospitalized for heart failure those with type 2 diabetes and hypoglycemia had a higher incidence of adverse cardiovascular events compared to those without diabetes.
  First Look, May 05, 2022
• Longer Use of Proton Pump Inhibitors Tied to Diabetes Risk 'Physicians should...avoid unnecessary prescription of this class of drugs, particularly for long-term use,' say study authors, but a gastroenterologist argues there isn't sufficient concern to alter practice.
  Medscape Medical News, May 04, 2022
• Newly Defined Liver Disorder Associated With COVID Mortality Metabolic dysfunction–associated fatty liver disease (MAFLD) may increase the risk from COVID-19.
  Medscape Medical News, May 03, 2022
• Vitamin D Shows Pancreatic Dysfunction Link in T2D With Obesity Higher levels of 25-hydroxy vitamin D (D3) linked with better pancreatic islet homeostasis in patients with short-duration type 2 diabetes and abdominal obesity in a cross-sectional Chinese study.
  First Look, May 02, 2022